Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01824550 · ClinicalTrials.gov registry record · NA

Home Exercise Intervention in Persons With Multiple Sclerosis

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
59
Enrollment target

NCT01824550: Completed NA study, sponsored by University of Illinois at Chicago.

NCT01824550 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01824550, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target

Study Summary

The objective of this study is to determine the effect of home-based, aerobic exercise training on subclinical atherosclerosis and mobility disability in persons with Multiple Sclerosis (MS). Our central hypothesis is that aerobic exercise training reduces both subclinical atherosclerosis and mobility disability.

Primary Outcome

This will me measured through carotid intima media thickness, flow mediated dilation of forearm, and aortic pulse wave velocity

Interventions

  • OTHER home-based exercise training condition

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2012-11-13
Est. Completion 2018-09-07
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT01824550 record still lists

NCT01824550 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which home-based exercise training condition is the first listed.

NCT01824550 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01824550 about?

NCT01824550 is a clinical study titled "Home Exercise Intervention in Persons With Multiple Sclerosis". The objective of this study is to determine the effect of home-based, aerobic exercise training on subclinical atherosclerosis and mobility disability in persons with Multiple Sclerosis (MS). Our central hypothesis is that aerobic exercise training reduces both subclinical atherosclerosis and mobili...

What is the current status of trial NCT01824550?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2012-11-13. Estimated completion is 2018-09-07.

What interventions are being tested in trial NCT01824550?

The interventions under investigation include: home-based exercise training condition (OTHER).

Who is sponsoring clinical trial NCT01824550?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01824550's enrollment target sits among peer trials

59 1256th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03801083 · 59 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

  • NCT04332367 · 59 participants · Phase 2

    Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

  • NCT05489575 · 59 participants · NA

    CPAP for the Treatment of Supine Hypertension

  • NCT06721689 · 59 participants · Phase 1

    PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01824550, the US trial registry maintained by the National Library of Medicine. NCT01824550 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.